INVO Fertility Return on Tangible Equity 2012-2025 | IVF
Current and historical return on tangible equity values for INVO Fertility (IVF) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| INVO Fertility Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $-0.03B | $0.00B | 828.57% |
| 2025-06-30 | $-0.03B | $-0.01B | 509.09% |
| 2025-03-31 | $-0.03B | $-0.02B | 400.00% |
| 2024-12-31 | $-0.01B | $0.01B | 250.00% |
| 2024-09-30 | $-0.01B | $-0.01B | 88.89% |
| 2024-06-30 | $-0.01B | $-0.01B | 75.68% |
| 2024-03-31 | $-0.01B | $-0.01B | 90.32% |
| 2023-12-31 | $-0.01B | $-0.01B | 152.38% |
| 2023-09-30 | $-0.01B | $-0.01B | 276.92% |
| 2023-06-30 | $-0.01B | $0.00B | 2200.00% |
| 2023-03-31 | $-0.01B | $0.00B | -1600.00% |
| 2022-12-31 | $-0.01B | $0.00B | -600.00% |
| 2022-09-30 | $-0.01B | $0.00B | -225.00% |
| 2022-06-30 | $-0.01B | $0.00B | -188.24% |
| 2022-03-31 | $-0.01B | $0.01B | -155.56% |
| 2021-12-31 | $-0.01B | $0.01B | -133.33% |
| 2021-09-30 | $-0.01B | $0.00B | -235.29% |
| 2021-06-30 | $-0.01B | $0.00B | -363.64% |
| 2021-03-31 | $-0.01B | $0.01B | -1200.00% |
| 2020-12-31 | $-0.01B | $0.01B | 533.33% |
| 2020-09-30 | $-0.01B | $0.00B | 125.00% |
| 2020-06-30 | $0.00B | $0.00B | 100.00% |
| 2020-03-31 | $0.00B | $0.00B | 80.00% |
| 2019-12-31 | $0.00B | $0.00B | 57.14% |
| 2019-09-30 | $0.00B | $0.00B | 61.54% |
| 2019-06-30 | $0.00B | $0.00B | 30.77% |
| 2019-03-31 | $0.00B | $0.00B | 85.71% |
| 2018-12-31 | $0.00B | $0.00B | 75.00% |
| 2018-09-30 | $0.00B | $0.00B | 44.44% |
| 2018-06-30 | $0.00B | $0.00B | 42.11% |
| 2018-03-31 | $0.00B | $-0.01B | 0.00% |
| 2017-12-31 | $0.00B | $-0.01B | 0.00% |
| 2017-09-30 | $0.00B | $-0.01B | 0.00% |
| 2017-06-30 | $0.00B | $-0.01B | 0.00% |
| 2017-03-31 | $0.00B | $-0.01B | 22.22% |
| 2016-12-31 | $0.00B | $-0.01B | 23.53% |
| 2016-09-30 | $0.00B | $0.00B | 25.00% |
| 2016-06-30 | $0.00B | $0.00B | 33.33% |
| 2016-03-31 | $0.00B | $0.00B | 200.00% |
| 2015-12-31 | $0.00B | $0.00B | 400.00% |
| 2015-09-30 | $0.00B | 533.33% | |
| 2015-06-30 | $0.00B | 266.67% | |
| 2015-03-31 | $0.00B | 0.00% | |
| 2011-12-31 | $0.00B | $0.00B | 0.00% |
| 2011-09-30 | $0.00B | $0.00B | 0.00% |
| 2011-06-30 | $0.00B | $0.00B | 0.00% |
| 2011-03-31 | $0.00B | $0.00B | 0.00% |
| 2010-12-31 | $0.00B | $0.00B | -44.44% |
| 2010-09-30 | $0.00B | $0.00B | -44.44% |
| 2010-06-30 | $0.00B | $0.00B | 66.67% |
| 2010-03-31 | $0.00B | $0.00B | 66.67% |
| 2009-12-31 | $0.00B | $0.00B | 145.45% |
| 2009-09-30 | $-0.01B | $-0.01B | 222.22% |
| 2009-06-30 | $0.00B | $0.00B | 200.00% |
| 2009-03-31 | $0.00B | $0.00B | 400.00% |
| 2008-12-31 | $0.00B | $0.00B | 400.00% |
| 2008-09-30 | $0.00B | $0.00B | 0.00% |
| 2008-06-30 | $0.00B | $0.00B | 0.00% |
| 2008-03-31 | $0.00B | $0.00B | 0.00% |
| 2007-12-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.002B | $0.007B |
| INVO Fertility Inc. is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics. INVO Fertility Inc., formerly known as NAYA Biosciences Inc., is based in SARASOTA, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $166.691B | 30.61 |
| HCA Healthcare (HCA) | United States | $107.089B | 17.73 |
| CVS Health (CVS) | United States | $99.777B | 11.47 |
| Elevance Health (ELV) | United States | $83.311B | 12.22 |
| Cencora (COR) | United States | $68.839B | 22.19 |
| Natera (NTRA) | United States | $31.987B | 0.00 |
| DiDi Global (DIDIY) | China | $23.485B | 21.70 |
| Labcorp Holdings (LH) | United States | $22.455B | 17.12 |
| Medpace Holdings (MEDP) | United States | $17.208B | 42.72 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.445B | 0.00 |
| Viatris (VTRS) | United States | $14.812B | 5.52 |
| BioMerieux (BMXMF) | France | $14.802B | 0.00 |
| ICON (ICLR) | Ireland | $14.747B | 14.63 |
| Solventum (SOLV) | United States | $13.786B | 13.38 |
| Revvity (RVTY) | United States | $12.755B | 23.49 |
| CochLear (CHEOY) | Australia | $11.760B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.813B | 20.83 |
| Avantor (AVTR) | United States | $8.291B | 12.67 |
| Sonic Healthcare (SKHHY) | Australia | $7.752B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.556B | 0.00 |
| HealthEquity (HQY) | United States | $7.294B | 27.27 |
| BrightSpring Health Services (BTSG) | United States | $7.070B | 42.15 |
| Bausch + Lomb (BLCO) | Canada | $6.078B | 39.91 |
| PACS (PACS) | United States | $6.072B | 36.92 |
| Sotera Health (SHC) | United States | $5.449B | 26.27 |
| Alignment Healthcare (ALHC) | United States | $4.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.124B | 54.86 |
| Concentras Parent (CON) | United States | $2.762B | 17.24 |
| Organon (OGN) | United States | $2.277B | 2.40 |
| Progyny (PGNY) | United States | $2.114B | 41.56 |
| Surgery Partners (SGRY) | United States | $2.057B | 26.50 |
| Establishment Labs Holdings (ESTA) | United States | $1.962B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.877B | 11.21 |
| Ardent Health (ARDT) | United States | $1.231B | 4.02 |
| Teladoc Health (TDOC) | United States | $1.115B | 0.00 |
| Nutex Health (NUTX) | United States | $1.080B | 8.26 |
| CareDx (CDNA) | United States | $1.029B | 16.82 |
| Omada Health (OMDA) | United States | $0.933B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.910B | 14.89 |
| InnovAge Holding (INNV) | United States | $0.794B | 0.00 |
| Embecta (EMBC) | United States | $0.734B | 4.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.706B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.594B | 0.00 |
| CryoPort (CYRX) | United States | $0.552B | 0.00 |
| Enhabit (EHAB) | United States | $0.532B | 23.91 |
| Strata Critical Medical (SRTA) | United States | $0.515B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.445B | 8.19 |
| Agilon Health (AGL) | United States | $0.423B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.51 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.288B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.279B | 58.75 |
| So-Young (SY) | China | $0.269B | 0.00 |
| KindlyMD (NAKA) | United States | $0.201B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.181B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.141B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.046B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.21 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.016B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |